Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid Cancer, Papillary 1

Interventions

Magnetic Resonance Spectroscopy 5lenvatinib 3cabozantinib 3Sunitinib 3Iodine-131 3trametinib 2selpercatinib 2dabrafenib 2Sorafenib 2Fluorodeoxyglucose F18 2AZD 6244 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vandetanib 1tremelimumab 1tovorafenib 1tanespimycin 1romidepsin 1pralsetinib 1pembrolizumab 1omipalisib 1durvalumab 1copanlisib 1cediranib 1alectinib 1aflibercept 1Vorinostat 1Vemurafenib 1Thyrotropin Alfa 1Thyroidectomy 1Thyroid (USP) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Thyroid Cancer, Papillary × Thyroid (USP) × Clear all
NCT01974284 2019-11-25

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

Yale University

Phase NA Terminated
7 enrolled 4 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡